Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

ABSTRACT: Sequencing of VRE isolates

PROVIDER: PRJNA773095 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR16506673_1.fastq.gz	Fastqsanger.gz
	SRR16506673_2.fastq.gz	Fastqsanger.gz
	SRR16506674_1.fastq.gz	Fastqsanger.gz
	SRR16506675_1.fastq.gz	Fastqsanger.gz
	SRR16506676_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 13

Similar Datasets

Project description:VRE blood culture isolates 2018-2021

| PRJNA1210141 | ENA

Project description:VRE sequencing

| PRJNA980408 | ENA

VRE isolates from entry-screening isolated in Germany

Project description:VRE isolates from entry-screening isolated in Germany

| PRJEB29744 | ENA

Project description:VRE

| PRJNA605642 | ENA

A comprehensive microarray analysis of Enterococcus faecium in response to vancomycin in combination with the essential oil components carvacrol and cuminaldehyde

Project description:This study aims to determine the global gene expression in vancomycin resistant Enterococcus faecium (VRE) in response to a novel essential oil-vancomycin combination, and the individual components (vancomycin, carvacrol and cuminaldehyde) to help determine the mechanism of action of this antimicrobial formulation. This formulation increases the susceptibility of VRE to vancomycin and the array provides data on the synergistic mechanism of action. Five conditions (1. Control; 2. Carvacrol, 1.98 mM; 3. Cuminaldehyde, 4.20 mM; 4. Vancomycin, 0.031 mg/l; 5. Combination, 1.98 mM Carvacrol, 4.2 mM Cuminaldehyde, 0.031 mg/l vancomycin) all with 1% DMSO were tested in triplicate with a 60 minute exposure time before extraction.

2019-12-31 | E-MTAB-8072 | biostudies-arrayexpress

T. brucei genomes

Project description:Shotgun sequencing of various T. brucei isolates

2016-01-04 | E-MTAB-3800 | biostudies-arrayexpress

Genome sequencing of vancomycin resistant Enterococcus faecium

Project description:Genome sequencing of VRE

| PRJEB6715 | ENA

Antibiofilm and antivirulence properties of 6-polyaminosteroid derivatives against antibiotic-resistant bacteria

Project description:The emergence of multi-drug resistant pathogens is a major public health problem, leading to rethink and innovate in our bacterial control strategies. Here, we explore the anti-biofilm and anti-virulence activities of nineteen 6-polyaminosterol derivatives (squalamine-based), presenting a modulation of their polyamine side chain, on 4 major pathogens, i.e. carbapenem-resistant A. baumannii (CRAB) and P. aeruginosa (CRPA), a methicillin-resistant S. aureus (MRSA) and a vancomycin-resistant E. faecium (VRE) strains. We screened the effect of these derivatives on biofilm formation and eradication. 4e (for CRAB, VRE and MRSA) and 4f (for all the strains) were the most potent one and displayed activities as good as conventional antibiotics. We also identified 11 compounds able to decrease by more than 40% the production of pyocyanin, a major virulence factor of P. aeruginosa. We demonstrated that 4f treatment acts against bacterial infections in Galleria mellonella and significantly prolonged the larvae survival (from 50% to 80%) after 24 h of CRAB, VRE and MRSA infections. As shown by proteomic studies, 4f triggered distinct cellular responses depending on the bacterial species, but essentially related to the cell envelop. Its interesting anti-biofilm and anti-virulence properties make it promising candidate for use in therapeutics.

2024-05-22 | PXD047333 | Pride

Project description:VRE ST1299

| PRJNA1096275 | ENA

Five phages against VRE

Project description:Complete genomes of five Enterococcus faecium virulent phages targeting VRE isolates

| PRJEB41784 | ENA